UnitedHealth Group Incorporated (UNH) Director Sells $1,250,536.00 in Stock

UnitedHealth Group Incorporated (NYSE:UNH) Director Gail R. Wilensky sold 5,600 shares of UnitedHealth Group stock in a transaction dated Wednesday, November 29th. The shares were sold at an average price of $223.31, for a total value of $1,250,536.00. Following the transaction, the director now owns 61,137 shares in the company, valued at approximately $13,652,503.47. The transaction was disclosed in a legal filing with the SEC, which is available through this link.

UnitedHealth Group Incorporated (NYSE:UNH) traded up $6.04 during trading hours on Thursday, hitting $228.17. The company’s stock had a trading volume of 6,845,851 shares, compared to its average volume of 3,107,043. The firm has a market cap of $209,588.95, a price-to-earnings ratio of 22.53, a price-to-earnings-growth ratio of 1.60 and a beta of 0.64. UnitedHealth Group Incorporated has a 52-week low of $155.18 and a 52-week high of $228.75. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.70 and a quick ratio of 0.70.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.57 by $0.09. The firm had revenue of $50.32 billion for the quarter, compared to analyst estimates of $50.38 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The business’s quarterly revenue was up 8.7% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.17 EPS. equities research analysts forecast that UnitedHealth Group Incorporated will post 10 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 12th. Investors of record on Friday, December 1st will be issued a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.31%. The ex-dividend date is Thursday, November 30th. UnitedHealth Group’s payout ratio is presently 33.26%.

Several hedge funds have recently bought and sold shares of the stock. Institutional & Family Asset Management LLC increased its holdings in shares of UnitedHealth Group by 4.6% during the 3rd quarter. Institutional & Family Asset Management LLC now owns 19,346 shares of the healthcare conglomerate’s stock worth $3,789,000 after acquiring an additional 857 shares during the last quarter. Steward Partners Investment Advisory LLC acquired a new position in shares of UnitedHealth Group during the 3rd quarter worth approximately $7,787,000. Visionary Asset Management Inc. acquired a new position in UnitedHealth Group in the 3rd quarter valued at $309,000. Jana Partners LLC acquired a new position in UnitedHealth Group in the 3rd quarter valued at $44,601,000. Finally, Public Employees Retirement System of Ohio grew its holdings in UnitedHealth Group by 1.2% in the 3rd quarter. Public Employees Retirement System of Ohio now owns 711,891 shares of the healthcare conglomerate’s stock valued at $139,424,000 after buying an additional 8,769 shares in the last quarter. 86.20% of the stock is currently owned by institutional investors and hedge funds.

Several research firms have recently weighed in on UNH. Wells Fargo & Company reiterated an “outperform” rating and set a $245.00 price objective (up previously from $230.00) on shares of UnitedHealth Group in a report on Wednesday. Oppenheimer boosted their target price on UnitedHealth Group from $215.00 to $225.00 and gave the company an “outperform” rating in a research note on Wednesday. Credit Suisse Group restated a “positive” rating and issued a $240.00 target price (up previously from $233.00) on shares of UnitedHealth Group in a research note on Wednesday. Royal Bank Of Canada boosted their target price on UnitedHealth Group to $244.00 and gave the company an “outperform” rating in a research note on Wednesday. They noted that the move was a valuation call. Finally, Piper Jaffray Companies boosted their target price on UnitedHealth Group to $242.00 and gave the company an “overweight” rating in a research note on Wednesday. Three equities research analysts have rated the stock with a hold rating and twenty-four have assigned a buy rating to the company’s stock. UnitedHealth Group has an average rating of “Buy” and an average target price of $220.34.

COPYRIGHT VIOLATION WARNING: “UnitedHealth Group Incorporated (UNH) Director Sells $1,250,536.00 in Stock” was posted by American Banking News and is the property of of American Banking News. If you are accessing this piece on another site, it was illegally stolen and republished in violation of U.S. & international copyright and trademark law. The correct version of this piece can be viewed at https://www.americanbankingnews.com/2017/11/30/unitedhealth-group-incorporated-unh-director-sells-1250536-00-in-stock.html.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Insider Buying and Selling by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply